Orchard Therapeutics’ Shareholder Rights Altered Post-Acquisition

Orchard Therapeutics PLC (ORTX) has released an update to notify the public and investors about a material modification to rights of security holders.

Kyowa Kirin International plc acquired all outstanding Company Ordinary Shares at the Effective Time, following the provisions of the Scheme of Arrangement and England and Wales laws. Consequently, shareholders no longer have rights in the Company Ordinary Shares, retaining only the rights provided by the Scheme of Arrangement, which includes the entitlement to the Merger Consideration.

For further insights into ORTX stock, check out TipRanks’ Stock Analysis page.